Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Viral chemokine-binding proteins.

Bruce T Seet¹, Grant McFadden

¹Department of Microbiology and Immunology, The University of Western Ontario, London, Ontario, Canada.

Journal of Leukocyte Biology

|July 9, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Divergence in poxvirus-encoded E3-like proteins can dictate poxvirus activation of cellular necroptosis.

Journal of virology·2026

Same author

Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response.

Science (New York, N.Y.)·2026

Same author

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement.

Scientific reports·2025

Same author

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication.

Viruses·2025

Same author

Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood-Brain Barrier and Treat Murine Glioma.

International journal of molecular sciences·2024

Same author

Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator.

Biomedicines·2024

Same journal

Correction to: IL-27 signaling negatively regulates FcɛRI-mediated mast cell activation and allergic response.

Journal of leukocyte biology·2026

Same journal

Autofluorescence enables detection and quantification of EETosis in human leukocyte cultures.

Journal of leukocyte biology·2026

Same journal

Cold Atmospheric Plasma as an Immunomodulator: Suppression of T-cell Hyperactivation and Graft-versus-Host Disease via Redox Regulation.

Journal of leukocyte biology·2026

Same journal

Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis.

Journal of leukocyte biology·2026

Same journal

Eosinophil Essentials: Identification and Assessment of Activity.

Journal of leukocyte biology·2026

Same journal

Immune cell landscape reveals 5 immune-related subtypes and molecular characteristics with prognostic and therapeutic implications in pan-cancer.

Journal of leukocyte biology·2026

See all related articles

Large DNA viruses like poxviruses and herpesviruses use secreted chemokine-binding proteins (CKBPs) to disrupt immune cell migration. Understanding these viral CKBPs offers therapeutic potential for chemokine-mediated diseases.

Area of Science:

Immunology
Virology
Molecular Biology

Background:

Chemokines are signaling proteins crucial for immune cell navigation during infection and inflammation.
Large DNA viruses, including poxviruses and herpesviruses, have developed strategies to interfere with the chemokine network.
Viral evasion tactics include mimicking chemokines or receptors, and producing secreted chemokine-binding proteins (CKBPs).

Purpose of the Study:

To review recent advancements in understanding secreted CKBPs encoded by poxviruses and herpesviruses.
To explore how viral CKBPs manipulate host immune responses.
To identify potential therapeutic applications targeting chemokine-mediated diseases.

Main Methods:

Literature review focusing on viral secreted chemokine-binding proteins (CKBPs).

Related Experiment Videos

Analysis of viral strategies for manipulating chemokine-GPCR interactions.

Discussion of the functional implications of viral CKBPs in immune modulation.

Main Results:

Viruses encode secreted CKBPs that bind chemokines, inhibiting their function.
These viral CKBPs lack sequence similarity to host proteins but effectively disrupt chemokine signaling.
Viral CKBPs represent a key strategy for large DNA viruses to subvert host immunity.

Conclusions:

Secreted viral CKBPs are potent modulators of the chemokine network.
Studying viral CKBPs provides insights into chemokine biology and immune evasion.
Targeting viral CKBPs may lead to novel therapies for inflammatory and infectious diseases.